30 Sep 2020 14:27
Â
Â
Motif Bio plc
Â
("Motif Bio" or the "Company")
Â
Result of AGM
Â
Motif Bio plc (AIM: MTFB) announces that at the Annual General Meeting of the Company held earlier today at the offices of ONE Advisory Limited, 201 Temple Chambers, 3-7 Temple Avenue, London, EC4Y 0DT all but one of the resolutions put to members were passed on a poll.
Â
The Board notes that resolution 7, which was proposed as a special resolution regarding the disapplication of pre-emption rights, was not passed.
Â
The number of votes lodged by proxy and voted on by poll for and against each of the resolutions proposed, and the number of votes withheld, were as follows:
Â
Resolution | FOR* | % | AGAINST | % | WITHHELD |
Resolution 1 (Ordinary) To receive the Company's annual accounts and the strategic, directors' and auditors' reports for the year ended 31 December 2019. | Â 37,371,686 | Â 91.94 Â | Â 3,275,355 | Â 8.06 Â | Â 131,590 |
Resolution 2 (Ordinary) To re-elect Graham Lumsden as a Director of the Company | Â 27, 167,596 | Â 66.74 Â | Â 13,541,866 | Â 33.26 Â | Â 69,169 |
Resolution 3 (Ordinary) To re-elect Christopher Wardhaugh as a director of the Company, who was appointed by the board since the last annual general meeting. | Â Â 34,740,854 | Â Â 85.42 Â | Â Â 5,930,684 | Â Â 14.58 Â | Â Â 107,093 |
Resolution 4 (Ordinary) To re-appoint the Company's auditor Crowe LLP, who have been appointed by the board since the last annual general meeting. | Â Â 37,286,396 | Â Â 91.56 Â Â | Â Â 3,437,066 | Â Â 8.44 Â | Â Â 55,169 |
Resolution 5 (Ordinary) That the Directors be authorised to fix the auditors remuneration. | Â 36,844,682 Â | Â 90.71 Â Â | Â 3,772,431 | Â 9.29 Â | Â 161,518 |
Resolution 6 (Ordinary) To empower the directors to allot relevant securities pursuant to Section 551 of the Act | Â 33,534,192 | Â 84.95 Â | Â 5,941,430 Â | Â 15.05 Â | Â 1,303,009 |
Resolution 7 (Special) To disapply the pre-emptive rights contained in Section 561 of the Act | Â 26,246,162 | Â 73.09 Â Â | Â 9,844,855 | Â 26.91 Â | Â 4,187,614 |
Â
Â
Â
*including votes granting discretion to the chair
Â
As at 30 September 2020, there were 654,991,023 ordinary shares in issue. Shareholders are entitled to one vote per share. Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.
Â
 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.
Â
For further information please contact:
 Motif Bio plc |  ir@motifbio.com |
Jonathan Gold (President and Chief Business Officer) | Â |
 |  |
 SP Angel Corporate Finance LLP (NOMAD & BROKER) |  +44 (0) 20 3470 0470 |
David Hignell/Caroline Rowe (Corporate Finance) | Â |
Vadim Alexandre/Abigail Wayne (Sales & Broking) | Â |
 |  |
Walbrook PR Ltd. (UK FINANCIAL PR & IR) | +44 (0) 20 7933 8780 |
Paul McManus/ Lianne Cawthorne | motifbio@walbrookpr.com |
Â